tiprankstipranks
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC

Arecor Therapeutics PLC (AREC) Share Price & Analysis

1 Followers

AREC Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range125.00p - 280.00p
Previous Close132.5p
Volume22.70K
Average Volume (3M)14.88K
Market Cap
£40.58M
Enterprise Value28.06M
Total Cash (Recent Filing)£12.81M
Total Debt (Recent Filing)£288.00K
Price to Earnings (P/E)-4.6
Beta-0.46
Sep 19, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume14,881
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

6.97%0.00%0.00%93.03%
6.97%
Insiders
0.00% Other Institutional Investors
93.03% Public Companies and
Individual Investors

AREC FAQ

What was Arecor Therapeutics PLC’s price range in the past 12 months?
Arecor Therapeutics PLC lowest share price was 125.00p and its highest was 280.00p in the past 12 months.
    What is Arecor Therapeutics PLC’s market cap?
    Currently, no data Available
    When is Arecor Therapeutics PLC’s upcoming earnings report date?
    Arecor Therapeutics PLC’s upcoming earnings report date is Sep 19, 2024 which is in 147 days.
      How were Arecor Therapeutics PLC’s earnings last quarter?
      Currently, no data Available
      Is Arecor Therapeutics PLC overvalued?
      According to Wall Street analysts Arecor Therapeutics PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Arecor Therapeutics PLC pay dividends?
        Arecor Therapeutics PLC does not currently pay dividends.
        What is Arecor Therapeutics PLC’s EPS estimate?
        Arecor Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Arecor Therapeutics PLC have?
        Arecor Therapeutics PLC has 30,626,986 shares outstanding.
          What happened to Arecor Therapeutics PLC’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Arecor Therapeutics PLC?
          Currently, no hedge funds are holding shares in GB:AREC
          ---

          Company Description

          Arecor Therapeutics PLC

          Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Arestat, it is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Avacta Group plc
          N4 Pharma
          4basebio UK Societas
          Achilles Therapeutics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis